Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17]

Absolute Antibody

Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17]

7

Specificty of the original mouse IgG1 version of this antibody to SARS-CoV-2 and SARS-Cov was confirmed by Specificty of the original mouse IgG1 version of this antibody to SARS-CoV-2 and SARS-Cov was confirmed by ELISA (Terry et al., 2021; pmid: 33714753). This antibody detected SARS-Cov-2 N protein in Western blot exhibiting labeling patterns suggesting a linear epitope (Terry et al., 2021; pmid: 33714753). mBG17 was shown to be very effective in staining SARS-Cov-2 N protein in immunofluorescence in SARS-Cov-2-infected Vero cells, both methanol and paraformaldehyde fixed (Terry et al., 2021; pmid: 33714753). Finally, the original version of mBG17 was demonstrated to be an effective detection antibody in a sandwich ELISA assay suggesting its potential use in SARS-Cov-2 diagnostics (Terry et al., 2021; pmid: 33714753).

ImmunoFluorescence, Western Blot, ELISA

ELISA; WB; IF

Research Use Only

Nucleoprotein

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

-20°C,2°C to 8°C

12352203